Russell Investments Group’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
Russell Investments Group's ALT Position: Q2 2026 in Review
Russell Investments Group increased its Altimmune (ALT) stake by 172% in Q2 2026, buying an estimated $82.4K and bringing the position to 43,696 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #3341.
Russell Investments Group first reported a position in ALT in Q4 2016 and has held it in 16 quarters since. The position peaked at $695K in Q4 2016. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Russell Investments Group held 43,696 shares of Altimmune worth $133K as of Q2 2026.
- Russell Investments Group bought 27,604 Altimmune shares in Q2 2026, an estimated $82.4K.
- Altimmune made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3341 holding.
- Russell Investments Group first reported a position in Altimmune in Q4 2016 and has held it in 16 quarters since.
- Russell Investments Group's Altimmune position peaked at $695K in Q4 2016.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.